✦ LIBER ✦

PIN56 Economic Value of Telaprevir for the Treatment of Previously Untreated F2 Fibrosis Chronic Hepatitis C Patients

✍ Scribed by S. Gavart; S. Lee; E.R. D'Angelo; R. DeMasi; S. Cure; F. Bianic

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PIN29 Cost Effectiveness Analysis of Add

✍ Ramachandran, S.; Mahabaleshwarkar, R.; Yang, Y. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB

PIN62 Cost-Effectiveness of Triple Thera

✍ J.T. Stahmeyer; S. Schauer; D. Wirth; J. Fleischmann; S. Lee; S. Gavart; F. Bian 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Peginterferon alfa-2b plus ribavirin for

✍ Stefan Zeuzem; Rolf Hultcrantz; Marc Bourliere; Tobias Goeser; Patrick Marcellin 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 220 KB

PIN32 Economic Evaluation of Boceprevir

✍ R. Odhiambo; J. Chhatwal; S.A. Ferrante; A. El Khoury; E. Elbasha 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

PGI16 Cost Effectiveness of Boceprevir P

✍ M. Fonseca; V. Garran; G.T. Araujo 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Cost-Effectiveness of Telaprevir Plus Pe

✍ Morais, A.D.; Pereira, M.L. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB